Latest Period
Q1 2026
Security Snapshot
Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS) Institutional Ownership
CUSIP: 171126204
13F Institutional Holders and Ownership History from Q3 2025 to Q1 2026
Institutions Reporting
17
Shares (Excl. Options)
912,311
Price
$21.01
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- PTHS on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 912,311
- Total 13F value
- $19,167,664
- Portfolio coverage rank
- 0%
- Share change
- -14,938
- Value change
- -$424,416
- Number of holders
- 17
- Shares outstanding
- 3,332,442
- SEC-reported price per share
- $24.82
- Insider filing price
- $24.82
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- PTHS - Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 171126204.
- 17 institutions reported positions in Q1 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 15 to 17 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $27,880,129 to $19,167,664.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 17 institutions filings for Q1 2026.
Security key
171126204
Latest holder period
Q1 2026
13F holders
17
13D/G owners
5
CIK / CUSIP context first
Open Q1 2026 holders
PTHS full holder history
Pelthos Therapeutics Inc. SEC filings
Pelthos Therapeutics Inc. company facts
Pelthos Therapeutics Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 171126204:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
PTHS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC | 50% | 0% | $145,296,959 | +$7,316,652 | 5,189,177 | +5.3% | Ligand Pharmaceuticals Incorporated | 06 Nov 2025 |
| 3i, LP | 9.9% | 0% | $7,751,598 | +$417,220 | 337,026 | +5.7% | 3i, LP | 31 Mar 2026 |
| Murchinson Ltd. | 9.1% | $7,840,000 | 280,000 | Murchinson Ltd. | 30 Sep 2025 | |||
| Ikarian Capital, LLC | 7.7% | -8.8% | $5,901,754 | +$19,320 | 256,598 | +0.33% | Ikarian Capital, LLC | 31 Mar 2026 |
| Friedberg Ezra M | 8.3% | 250,121 | Ezra Friedberg | 01 Jul 2025 |
As of 31 Mar 2026, 17 institutional investors reported holding 912,311 shares of Pelthos Therapeutics Inc. - Common Stock, par value $0.0001 per share (PTHS). This represents 27% of the company’s total 3,332,442 outstanding shares.
13F concentration
Top 19 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
27%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Murchinson Ltd. | 8.9% | 296,314 | +2.4% | 2.5% | $6,225,557 |
| Ikarian Capital, LLC | 7.7% | 256,598 | +0.33% | 0.78% | $5,391,124 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.8% | 93,093 | 0% | 0% | $1,955,884 |
| BOOTHBAY FUND MANAGEMENT, LLC | 2.5% | 81,858 | +1.5% | 0.04% | $1,719,837 |
| J. Goldman & Co LP | 1.5% | 50,415 | -35% | 0.05% | $1,059,219 |
| CANTOR FITZGERALD, L. P. | 1.2% | 41,423 | +18% | 0.03% | $870,297 |
| DIADEMA PARTNERS LP | 0.74% | 24,773 | -0.91% | 0.23% | $520,481 |
| Knott David M Jr | 0.63% | 21,073 | +9.3% | 0.26% | $442,744 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.46% | 15,290 | +12% | 0% | $321,242 |
| Pale Fire Capital SE | 0.39% | 12,919 | +59% | 0.02% | $271,428 |
| VANGUARD FIDUCIARY TRUST CO | 0.29% | 9,817 | 0% | 0% | $206,255 |
| Persistent Asset Partners Ltd | 0.18% | 6,007 | 0% | 0.05% | $126,207 |
| Steward Partners Investment Advisory, LLC | 0.06% | 1,910 | 0% | 0% | $40,129 |
| UBS Group AG | 0.02% | 764 | +76% | 0% | $16,051 |
| Farther Finance Advisors, LLC | 0% | 40 | 0% | $852 | |
| Aspect Partners, LLC | 0% | 16 | 0% | $336 | |
| CITIGROUP INC | 0% | 1 | 0% | $21 | |
| MILLENNIUM MANAGEMENT LLC | 0% | 0 | -100% | $0 | |
| BANK OF AMERICA CORP /DE/ | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q1 2026
Rows shown
1-3 of 3